HLS Therapeutics Inc (OTCPK:HLTRF)
$ 2.73 0.19 (7.48%) Market Cap: 83.68 Mil Enterprise Value: 134.75 Mil PE Ratio: 0 PB Ratio: 1.02 GF Score: 58/100

Q2 2023 HLS Therapeutics Inc Earnings Call Transcript

Aug 10, 2023 / 12:30PM GMT
Release Date Price: $4.55
Operator

Good morning and welcome to the Q2 2023 Financial Results Conference Call for HLS Therapeutics. On this morning's call, we have Craig Millian, Chief Executive Officer and Tim Hendrickson, Chief Financial Officer. (Operator Instructions) Earlier this morning HLS issued a news release announcing its financial results for the 3 and 6 months ended June 30th, 2023. This news release along with the company's MD&A and financial statements are available on HLS's website and on SEDAR. Please note that the slides accompanying today's call can be viewed via the webcast, a link of which is available on the company's earnings press release and on its website on the events page.

Certain matters discussed in today's conference call or answers that may be given to questions could constitute forward looking statements. Actual results could differ materially from those anticipated. Risk factors that could affect results are detailed in the company's annual information form, which have been filed on SEDAR at www.sedar.com. During the conference call,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot